(Q50940035)

25 March 2018

title

Mutation (677 C to T) in the methylenetetrahydrofolate reductase gene aggravates hyperhomocysteinemia in hemodialysis patients. (English)

1 reference

25 March 2018

author name string

Födinger M

1

1 reference

25 March 2018

Mannhalter C

2

1 reference

25 March 2018

Wölfl G

3

1 reference

25 March 2018

Pabinger I

4

1 reference

25 March 2018

Müller E

5

1 reference

25 March 2018

Schmid R

6

1 reference

25 March 2018

Hörl WH

7

1 reference

25 March 2018

Sunder-Plassmann G

8

1 reference

25 March 2018

language of work or name

English

0 references

publication date

1 August 1997

1 reference

25 March 2018

published in

Kidney International

1 reference

25 March 2018

volume

52

1 reference

25 March 2018

issue

2

1 reference

25 March 2018

page(s)

517-523

1 reference

25 March 2018

https://scigraph.springernature.com/pub.10.1038/ki.1997.362

exact match

0 references

cites work

The pathogenesis of homocysteinemia: interruption of the coordinate regulation by S-adenosylmethionine of the remethylation and transsulfuration of homocysteine

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.362

7 January 2021

Hyperhomocyst(e)inemia as a risk factor for occlusive vascular disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.362

7 January 2021

Hyperhomocysteinemia: an independent risk factor for vascular disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.362

7 January 2021

Plasma homocyst(e)ine: a risk factor for arterial occlusive diseases

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.362

7 January 2021

Hyperhomocysteinemia as a risk factor for deep-vein thrombosis.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.362

7 January 2021

Accumulation of sulphur-containing amino acids including cysteine-homocysteine in patients on maintenance haemodialysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.362

7 January 2021

Plasma protein-bound homocyst(e)ine in patients requiring chronic haemodialysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.362

7 January 2021

Altered plasma free and protein-bound sulfur amino acid levels in patients undergoing maintenance hemodialysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.362

7 January 2021

Hyperhomocysteinemia and traditional cardiovascular disease risk factors in end-stage renal disease patients on dialysis: a case-control study.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.362

7 January 2021

Hyperhomocysteinemia as a risk factor for cardiovascular disease in patients undergoing hemodialysis.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.362

7 January 2021

Hyperhomocysteinemia confers an independent increased risk of atherosclerosis in end-stage renal disease and is closely linked to plasma folate and pyridoxine concentrations.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.362

7 January 2021

Homocystinemia. Vascular injury and arterial thrombosis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.362

7 January 2021

Homocystine-induced arteriosclerosis. The role of endothelial cell injury and platelet response in its genesis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.362

7 January 2021

Endothelial cell injury due to copper-catalyzed hydrogen peroxide generation from homocysteine

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.362

7 January 2021

Adverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.362

7 January 2021

Homocysteine, EDRF, and endothelial function

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.362

7 January 2021

Induction of cyclin A gene expression by homocysteine in vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.362

7 January 2021

Homocystinuria associated with decreased methylenetetrahydrofolate reductase activity

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.362

7 January 2021

Higher total plasma homocysteine in vitamin B12 deficiency than in heterozygosity for homocystinuria due to cystathionine beta-synthase deficiency

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.362

7 January 2021

Hyperhomocysteinemia and low pyridoxal phosphate. Common and independent reversible risk factors for coronary artery disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.362

7 January 2021

Homocysteinemia due to folate deficiency

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.362

7 January 2021

Vitamins as homocysteine-lowering agents

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.362

7 January 2021

A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.362

7 January 2021

Determination of free and total homocysteine in human plasma by high-performance liquid chromatography with fluorescence detection

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.362

7 January 2021

Methylenetetrahydrofolate reductase polymorphism, plasma folate, homocysteine, and risk of myocardial infarction in US physicians

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.362

7 January 2021

Thermolabile methylenetetrahydrofolate reductase in patients with coronary artery disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.362

7 January 2021

Homocysteine and risk of premature coronary heart disease. Evidence for a common gene mutation

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.362

7 January 2021

Accelerated atherosclerosis in prolonged maintenance hemodialysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.362

7 January 2021

Cardiovascular risk factors in chronic renal failure and hemodialysis populations

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.362

7 January 2021

Mortality risk factors in patients treated by chronic hemodialysis. Report of the Diaphane collaborative study

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.362

7 January 2021

High dose-B-vitamin treatment of hyperhomocysteinemia in dialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.362

7 January 2021

Sulphur containing amino acids in chronic renal failure with particular reference to homocystine and cysteine-homocysteine mixed disulphide

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.362

7 January 2021

Early alterations of plasma free amino acids in chronic renal failure.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.362

7 January 2021

Protein-Bound Homocyst(e)ine in Normal Subjects and in Patients with Homocystinuria

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.362

7 January 2021

Homocystine uptake in isolated rat renal cortical tubules

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.362

7 January 2021

Development of methyltransferase activities of human fetal tissues.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.362

7 January 2021

Increased levels of plasma homocysteine are associated with nephropathy, but not severe retinopathy in type 1 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.362

7 January 2021

Mechanism of erythrocyte accumulation of methylation inhibitor S-adenosylhomocysteine in uremia

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.362

7 January 2021

Folate status is the major determinant of fasting total plasma homocysteine levels in maintenance dialysis patients.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.362

7 January 2021

Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.362

7 January 2021

Folic acid--an innocuous means to reduce plasma homocysteine.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.362

7 January 2021

Treatment of hyperhomocyst(e)inemia: physiological basis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1997.362

7 January 2021

Identifiers

DOI

10.1038/KI.1997.362

1 reference

25 March 2018

Dimensions Publication ID

0 references

1 reference

25 March 2018